| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
29,500,000 |
| Market
Cap: |
56.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.365 - $4.91 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cue Biopharma is a biopharmaceutical company engineering a class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body. Co. is focusing on drug product candidates for treating cancer in its CUE-100 series, which exploits rationally engineered interleukin 2, in context of the key Immuno- Selective Targeting and Alteration of T Cells framework for selective activation of targeted tumor-specific T cells. Co. is seeking third party support through partnerships and collaborations, or alternative funding structures, to further develop its programs outside of oncology, including its CUE-200, CUE-300 and CUE-400 series.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,000 |
240,000 |
| Total Buy Value |
$0 |
$0 |
$19,620 |
$836,320 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
9,325 |
| Total Sell Value |
$0 |
$0 |
$0 |
$30,586 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Suri Anish |
President and CSO |
• – – |
2020-10-05 |
4 |
D |
$16.30 |
$159,740 |
D/D |
(9,800) |
58,091 |
|
- |
|
| Suri Anish |
President and CSO |
• – – |
2020-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,333 |
67,891 |
|
- |
|
| Gray Cameron |
Director |
– • – |
2020-09-30 |
4 |
B |
$15.30 |
$76,500 |
D/D |
5,000 |
677,500 |
2.39 |
3% |
|
| Gray Cameron |
Director |
– • – |
2020-09-29 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
672,500 |
2.39 |
3% |
|
| Millar Kerri-Ann |
CFO |
• – – |
2020-08-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,900) |
5,766 |
|
- |
|
| Millar Kerri-Ann |
CFO |
• – – |
2020-08-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
7,666 |
|
- |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4/A |
AS |
$20.00 |
$267,480 |
D/D |
(13,374) |
17,125 |
|
- |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4/A |
OE |
$7.50 |
$100,305 |
D/D |
13,374 |
30,499 |
|
- |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4 |
AS |
$20.00 |
$265,480 |
D/D |
(13,274) |
17,125 |
|
-36% |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-05 |
4 |
OE |
$7.50 |
$99,555 |
D/D |
13,274 |
30,399 |
|
- |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-05 |
4 |
AS |
$20.01 |
$16,008 |
D/D |
(800) |
34,558 |
|
-36% |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-05 |
4 |
OE |
$6.42 |
$5,136 |
D/D |
800 |
35,358 |
|
- |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-04 |
4 |
AS |
$20.05 |
$4,030 |
D/D |
(201) |
17,125 |
|
-32% |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-04 |
4 |
OE |
$7.50 |
$1,508 |
D/D |
201 |
17,326 |
|
- |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-04 |
4 |
AS |
$20.14 |
$8,056 |
D/D |
(400) |
34,558 |
|
-32% |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-04 |
4 |
OE |
$6.42 |
$2,568 |
D/D |
400 |
34,958 |
|
- |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-03 |
4 |
AS |
$20.00 |
$128,500 |
D/D |
(6,425) |
17,125 |
|
-32% |
|
| Sandercock Colin |
SVP, General Counsel and Sec |
• – – |
2020-08-03 |
4 |
OE |
$7.50 |
$48,188 |
D/D |
6,425 |
23,550 |
|
- |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-03 |
4 |
AS |
$20.01 |
$116,058 |
D/D |
(5,800) |
34,558 |
|
-32% |
|
| Suri Anish |
President and CSO |
• – – |
2020-08-03 |
4 |
OE |
$6.42 |
$40,916 |
D/D |
5,800 |
40,358 |
|
- |
|
| Fletcher Aaron G.l. |
Director |
– • – |
2020-06-24 |
4 |
B |
$24.64 |
$186,572 |
D/D |
7,500 |
158,452 |
2.39 |
-50% |
|
| Suri Anish |
President and CSO |
• – – |
2020-03-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,354) |
34,558 |
|
- |
|
| Suri Anish |
President and CSO |
• – – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
39,912 |
|
- |
|
| Marlett Christopher A |
Director |
– • – |
2019-12-31 |
4 |
S |
$15.71 |
$141,390 |
D/D |
(9,000) |
0 |
|
-73% |
|
| Marlett Christopher A |
Director |
– • – |
2019-12-31 |
4 |
S |
$15.77 |
$105,659 |
I/I |
(6,700) |
768,503 |
|
-73% |
|
112 Records found
|
|
Page 3 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.27 (12.39%) 
